Does Continuous Vital Sign Monitoring Increase Investigations and Interventions in Complication-free Patients?
NCT ID: NCT06361862
Last Updated: 2025-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
700 participants
INTERVENTIONAL
2024-01-01
2025-04-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization
NCT05378139
Postoperative Complications in Cancer Patients Monitored With Intelligent Continuous Monitoring System
NCT06269198
Continuous Monitoring of Vital Parameters for Early Detection of Clinical Deterioration in Hospitalized Patients
NCT04305262
Continuous and Wireless Vital Sign Monitoring in Patients at Home After Acute Medical Admission
NCT05536206
Automated Alerts of Patient Deterioration vs. Routine Monitoring of High-risk Patients Admitted to Medical Wards
NCT04661748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
inactive alarms
Patients with continuous monitoring without active alerts from WARD.
No interventions assigned to this group
active alarms
Patients with continuous monitoring with active alerts from WARD.
Active alarms from WARD software
Wireless continuous vital sign monitoring with real time staff alerts
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active alarms from WARD software
Wireless continuous vital sign monitoring with real time staff alerts
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bispebjerg Hospital
OTHER
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eske Kvanner Aasvang
Professor, head of research, MD, DmSci
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eske Kvanner Aasvang
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WARD - Overtreatment
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.